These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17620757)

  • 41. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mortality and loss to follow-up among HAART initiators in rural South Africa.
    MacPherson P; Moshabela M; Martinson N; Pronyk P
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):588-93. PubMed ID: 19012940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Point-of-care tests for diagnosing infections in the developing world.
    Peeling RW; Mabey D
    Clin Microbiol Infect; 2010 Aug; 16(8):1062-9. PubMed ID: 20670288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Field experience in implementing ISO 15189 in Kisumu, Kenya.
    Zeh CE; Inzaule SC; Magero VO; Thomas TK; Laserson KF; Hart CE; Nkengasong JN;
    Am J Clin Pathol; 2010 Sep; 134(3):410-8. PubMed ID: 20716797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV testing strategies across European countries.
    Mounier-Jack S; Nielsen S; Coker RJ
    HIV Med; 2008 Jul; 9 Suppl 2():13-9. PubMed ID: 18557864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya.
    Chakaya JM; Mansoer JR; Scano F; Wambua N; L'Herminez R; Odhiambo J; Mohamed I; Kangangi J; Ombeka V; Akeche G; Adala S; Gitau S; Maina J; Kibias S; Langat B; Abdille N; Wako I; Kimuu P; Sitienei J
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):424-9. PubMed ID: 18371269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nursing implications of routine provider-initiated HIV testing and counselling in sub-Saharan Africa: a critical review of new policy guidance from WHO/UNAIDS.
    Evans C; Ndirangu E
    Int J Nurs Stud; 2009 May; 46(5):723-31. PubMed ID: 19159879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology of HIV-associated tuberculosis in rural Cambodia.
    Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.
    Perkins MD; Cunningham J
    J Infect Dis; 2007 Aug; 196 Suppl 1():S15-27. PubMed ID: 17624822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.
    Murphy RA
    Clin Infect Dis; 2008 Jun; 46(11):1729-32. PubMed ID: 18426372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Research in situ.
    Grant RM
    Nat Methods; 2007 Nov; 4(11):887-90. PubMed ID: 17952085
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda.
    Lorent N; Mugwaneza P; Mugabekazi J; Gasana M; Van Bastelaere S; Clerinx J; Van den Ende J
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):392-6. PubMed ID: 18371264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fragile environments of inexpensive CD4+ T-cell enumeration in the least developed countries: strategies for accessible support.
    Larsen CH
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S107-16. PubMed ID: 18228565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania.
    Ishengoma DS; Kamugisha ML; Rutta AS; Kagaruki GB; Kilale AM; Kahwa A; Kamugisha E; Baraka V; Mandara CI; Materu GS; Massaga JJ; Magesa SM; Lemnge MM; Mboera LE
    BMC Health Serv Res; 2017 Jan; 17(1):70. PubMed ID: 28114988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experiences in establishing a PEPFAR-supported laboratory quality system in Nigeria.
    Abimiku AG; Croxton T; Akintunde E; Okelade B; Jugu J; Peters S; Dakum P; Blattner W; Constantine N
    Am J Clin Pathol; 2010 Oct; 134(4):541-9. PubMed ID: 20855634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viewpoint TB diagnostics: what does the world really need?
    Weyer K; Carai S; Nunn P
    J Infect Dis; 2011 Nov; 204 Suppl 4():S1196-202. PubMed ID: 21996702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.